AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo

BSE540.80-18.05 (-3.23 %)

PREV CLOSE ( ) 558.85

OPEN PRICE ( ) 559.95

BID PRICE (QTY) 540.80 (349)

OFFER PRICE (QTY) 541.10 (84)

VOLUME 63398

TODAY'S LOW / HIGH ( )540.80 559.95

52 WK LOW / HIGH ( )521 1043

NSE543.35-15.45 (-2.76 %)

PREV CLOSE( ) 558.80

OPEN PRICE ( ) 557.95

BID PRICE (QTY) 543.15 (103)

OFFER PRICE (QTY) 543.35 (148)

VOLUME 977792

TODAY'S LOW / HIGH( ) 542.00 557.95

52 WK LOW / HIGH ( )520.85 1043.1

More From Company Profile

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 26-12 1986

Management Info

K Ragunathan - Chairman - Managing Director

Registered Office

Address Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone 040-23736370/23747340

Email info@aurobindo.com

Website www.aurobindo.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE, MCX

NEWS

12May Completion Of US FDA Inspection At Ou
Sub: Completion of US FDA Inspection at our Unit VII - Reg., Pursuan..

11May Aurobindo Pharma gets 6 observations f
The United States Food and Drug Administration (US FDA) has inspected Au..

04May Aurobindo Pharma’s arm gets USFDA appr
Aurobindo Pharma’s wholly owned subsidiary company -- Eugia Pharma Speci..

04May Announcement under Regulation 30 (LOD
We enclose a copy of the Press Release that is being issued by the Compa..

25Apr Aurobindo Pharma’s unit recalls Cyanoc
Aurobindo Pharma’s unit -- Aurobindo Pharma USA Inc is recalling Cyanoco..

Financials

in Millions

	QTR Dec 21	ANNUAL 21
Net Profit	2398.1	31129.1
Gross Profit	2424.6	41930.1
Operating Profit	3472	47096.8
Net Sales	26230.5	158236.8

EVENT CALENDAR

peer group

Dr. Reddy's Lab (BSE) 4347.60 (1.72%)	M.Cap ( in Cr)72330.34
Shilpa Medicare (BSE) 449.85 (9.64%)	M.Cap ( in Cr)3983.34
Hikal (BSE) 400.30 (9.01%)	M.Cap ( in Cr)4906.14
Kwality Pharma (BSE) 417.10 (5.00%)	M.Cap ( in Cr)432.79
Hester Biosciences (BSE) 2246.10 (0.60%)	M.Cap ( in Cr)1926.76

	NON-INSTITUTION	9.86%
	PROMOTERS	51.83%
	FI/BANKS/INSURANCE	5.73%
	MUTUAL FUNDS/UTI	10.09%
	GOVERNMENT	0%
	FII	0%

Scheme Name	Hold(%)
UTI Healthcare Fund...	6.38
Aditya Birla SL Pha...	4.93
Nippon India Pharma...	4.74
IDBI Healthcare Fun...	4.73
SBI Healthcare Opp ...	4.51
Nippon India Nifty ...	4.20

About Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd. was incorporated in the year 1986. Its today's share price is 540.8. Its current market capitalisation stands at Rs 32059.63 Cr. In the latest quarter, company has reported Gross Sales of Rs. 158758.2 Cr and Total Income of Rs.164135.4 Cr. The company's management includes B Adi Reddy, Girish Paman Vanvari, Savita Mahajan, Avnit Bimal Singh, PV Ramprasad Reddy, P Sarath Chandra Reddy, M Madan Mohan Reddy, M Sivakumaran, K Nithyananda Reddy, K Ragunathan.

It is listed on the BSE with a BSE Code of 524804 , NSE with an NSE Symbol of AUROPHARMA and ISIN of INE406A01037. It's Registered office is at Plot No. 2,Maitrivihar ,AmeerpetHyderabad-500038, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Associates LLP, K Nagaraju & Associates, SR Batliboi & Associates, SR Batliboi & Associates LLP, SR Batliboi & Co

About Nirmal Bang About Nirmal Bang Awards & Accolades Careers at Nirmal Bang Contact Nirmal Bang

Product & Services Equity & Derivatives Trading Forex Trading Commodity Trading Institutional Broking Depository Services Loan Against Securities (LAS) Algo Trading

Equity Price Analysis Volume Analysis Index Analysis News Analysis Corporate Action India Market Other Market Share Market Holidays

Derivatives Updates Market Report Overview

IPO IPO Issues Performance News & Analysis

Commodities Market Movers News & Commentary MCX / NCDEX Holidays MCX Data feed product and Charges

Mutual Funds About Nirmal Bang Niveshalaya Why Associate with Nirmal Bang Mutual Fund Login Mutual Fund Register FAQs Mutual Fund Holidays SIP Calculator Mutual Funds Updates Mutual Funds Trends Mutual Fund Reports Annual Return 2018 Annual Return 2017 Mutual Fund Terms & Conditions Mutual Privacy Policy

Nirmal Bang Research Technical Calls Equity Reports Commodity Reports Currency Research Institutional Research

Nirmal Bang Media Knowledge Center Blog Support Center Become A Partner Beyond Market Careers Sitemap

Other Links Disclaimer Privacy Policy Terms Of Use Rules & Regulations Disclosures Grievances SEBI Scores RMS Policy Inspection CSR Committee CSR Policy CSR Activities Investor Charter Linked content_Investor Charter for Depositories and DPs Investor Charter for Depositories and DPs

Investor Complaint Data

Connect with Us

ATTENTION INVESTORS Depository IPO KYC

Inactive account treatment NBSPL Policy of AML NBEPL Policy of AML NBSPL CSR Policy Physical Settlement Policy of Derivative Aadhar Updation Nirmalbang Privacy Policy V1.0 Documents in Vernacular Languages NBSPL Disclosure Document March 2019

Nirmal Bang Securities Pvt. Ltd. : Member NSE – ID 09391, SEBI Registration No. NSE CM Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE FO Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE CDS Segment INZ000202536, Member NSE Commodity – ID 09391, SEBI Registration No. NSE COMMODITY Segment Exchange Registered Broker, Member MSEI – ID 1067, SEBI Registration No. MSEI CM Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI FO Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI CDS Segment INZ000202536, Member MCX – ID 56460, SEBI Registration No. MCX COMMODITY Segment INZ000202536, Member NCDEX – ID 1268, SEBI Registration No. NCDEX COMMODITY Segment NZ000202536, Member ICEX – ID 2073, SEBI Registration No. ICEX COMMODITY Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CM Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE FO Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CDS Segment Exchange Registered Broker, Member BSE Commodity – ID 0498, SEBI Registration No. BSE COMMODITY Segment Exchange Registered Broker, SEBI Registration No. PMS INP000002981, SEBI Registration No. Research Analyst INP000002981, SEBI Registration No. DP Participants NSDL – CDSL IN-DP-CDSL 37-99,Member Comtrack Participant Id – ID 50274, Member NERL RP Id– ID R1447, Nirmal Bang Equities Private Limited Member BSE – ID 245, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. NSE FO Segment INZ000186135, Member NSE Currency – ID 13437, SEBI Registration No. NSE CDS Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI CM Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI FO Segment INZ000186135, SEBI Registration No. Research Analyst Segment INH000001436, Nirmal Bang Commodities Private Limited Member MCX – ID 16590, SEBI Registration No. MCX COMMODITY Segment INZ000043630, Member NCDEX – ID 00362, SEBI Registration No. NCDEX COMMODITY Segment INZ000043630, Member ICEX – ID 1165, SEBI Registration No. ICEX COMMODITY Segment INZ000043630, Member NCDEX Spot Exchange – ID 10084,Comtrack Participant CPID -5040, Participant CDSL Commodity Repository Limited - 12013300

For any grievances, please get in touch on 022-62739390 and write a mail to Contact@nirmalbang.com with Subject line as Grievances/Complain. |

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Type	Charges (POA Clients)	Charges (Non-POA Clients)
Margin Pledge Creation/Initiation	INR 10.00 (Per Transaction)	INR 20.00 (Per Transaction)
Margin Pledge Release	INR 10.00 (Per Transaction)	INR 20.00 (Per Transaction)

Stock Price Quote